Vitamin D is on a roll! Recent studies have linked Vitamin D deficiency to a wide variety of ailments. There have been several recent studies indicating that autism may be caused in part by Vitamin D deficiency in the pregnant mother or in the child. This morning similar studies came out with regard to Multiple Sclerosis:
Ray Kurzweil co-authored Fantastic Voyage, which in my opinion is the
best book written to date on life extension. A revised edition should
be released later this year.
Google and Nasa back new school for futurists
By David Gelles in San Francisco
Published: February 3 2009 05:02 | Last updated: February 3 2009 05:02
Google and Nasa are throwing their weight behind a new school for
futurists in Silicon Valley to prepare scientists for an era when
machines become cleverer than people.
The new institution, known as "Singularity University", is to be
headed by Ray Kurzweil, whose predictions about the exponential pace
of technological change have made him a controversial figure in
technology circles.
EDITOR'S CHOICE
Tech Blog: Tales from Topographic Oceans - Oct-17In depth: Browser
battles - Sep-03Google and Nasa's backing demonstrates the growing
mainstream acceptance of Mr Kurzweil's views, which include a claim
that before the middle of this century artificial intelligence will
outstrip human beings, ushering in a new era of civilisation.
To be housed at Nasa's Ames Research Center, a stone's-throw from the
Googleplex, the Singularity University will offer courses on
biotechnology, nano-technology and artificial intelligence.
The so-called "singularity" is a theorised period of rapid
technological progress in the near future. Mr Kurzweil, an American
inventor, popularised the term in his 2005 book "The Singularity is
Near".
Proponents say that during the singularity, machines will be able to
improve themselves using artificial intelligence and that smarter-
than-human computers will solve problems including energy scarcity,
climate change and hunger.
Yet many critics call the singularity dangerous. Some worry that a
malicious artificial intelligence might annihilate the human race.
Mr Kurzweil said the university was launching now because many
technologies were approaching a moment of radical advancement. "We're
getting to the steep part of the curve," said Mr Kurzweil. "It's not
just electronics and computers. It's any technology where we can
measure the information content, like genetics."
The school is backed by Larry Page, Google co-founder, and Peter
Diamandis, chief executive of X-Prize, an organisation which provides
grants to support technological change.
"We are anchoring the university in what is in the lab today, with an
understanding of what's in the realm of possibility in the future,"
said Mr Diamandis, who will be vice-chancellor. "The day before
something is truly a breakthrough, it's a crazy idea."
Despite its title, the school will not be an accredited university.
Instead, it will be modelled on the International Space University in
Strasbourg, France, the interdisciplinary, multi-cultural school that
Mr Diamandis helped establish in 1987.
Copyright The Financial Times Limited 2009
60 Minutes
Blunder: News Report On Resveratrol Overlooks Longevinex® Which
Activates More Longevity Genes Than Resveratrol Red Wine Molecule Or
Calorie Restricted Diet
San Dimas, CA (Jan
31, 2009) – In a recent episode of 60 Minutes, newsman Morley Safer
seemed was mistakenly led by researchers to believe the only current
way to add more healthy year to one's lifespan is to drink impossible
amounts of red wine (1000 bottles a day) or wait for a drug company to
invent a magic pill based on resveratrol, a substance found in the skin
of grapes and concentrated in red wine.What 60
Minutes viewers weren't told was that Longevinex®, a leading dietary
supplement already on the market, now provides such benefits to
consumers, as proven in a recent gene array study, according to its
spokesman, Bill Sardi.
"The French are
drinking 3 to 5 glasses of dark, aged, red wine per day and living
longer and healthier than populations in other developed nations," says Sardi. The French have far more
centenarians per capita than any other country, a testament to the
healthy properties of red wine.The new and more
economical option to red wine is to consume pills that provide
concentrated red wine molecules, like resveratrol, quercetin and
ferulic acid, says Sardi. While there has been considerable attention
given to one red wine molecule, resveratrol, a recent study shows an
array of natural molecules produces a more profound genomic effect than
plain resveratrol.
In a head-to-head
comparison, a unique patent-applied for matrix of molecules
(resveratrol, quercetin, IP6 rice bran) as provided in Longevinex®
activated 9-fold more longevity genes (1711) than plain resveratrol
(225 genes) or a calorie restricted diet.(198 genes) at a dose of
resveratrol 17-320 times lower than prior studies.
Researchers
interviewed on 60 MINUTES failed to mention a study published last
September in Experimental Gerontology which showed that
Longevinex® rapidly mimicked the genomic effect of calorie restriction
in laboratory mice, an effect that otherwise takes life-long food
deprivation to produce. [Experimental Gerontology 2008 Sept;
43(9):859-66] The public was deprived of hearing about a major
breakthrough in longevity science.
Studies show the
healthy range of wine consumption is 3-5 glasses a day. Sardi says the
point of a well designed red wine pill is to provide about the same
quantity of mineral-controlling molecules provided in 3-to-5 glasses of
red wine, or about 180-300 mg, without the alcohol, sugar, calories and
sulfite preservatives, at a cost that ~5-6 times less than wine. A $6
bottle of wine would cost ~3-5 a day to provide health benefits. The
cost of Longevinex®, a red wine pill designed to provide the equivalent
amount of molecules found in 3-5 glasses of wine, is less than $1 per
day.
Researchers
interviewed on 60 Minutes also failed to mention that mega-dose (360 mg
and 1565 mg human equivalent) resveratrol shortened the lives of
laboratory mice in a study published in August of 2008. [Cell
Metabolism 2008 August; 8(2):157-68] "Lower doses and multiple
molecules, as provided in Longevine®x, work
better and are safer, as attested by red wine drinkers," says Sardi.
Morley Safer,
reporter for CBS' 60 MINUTES, ended his report by asking: "When do
WE get this pill?" The best answer, short of conducting 99-year
human studies, is to consume the same amount of red wine molecules as
the French, about 180-300 milligrams per day, "which is what
Longevinex® provides," says Sardi.
The genomic study
comparing a calorie restricted diet, plain resveratrol and Longevinex®
can be viewed online at www.longevinex.com ####
Lots Of Unanswered Questions After CBS 60 Minutes
Report.
Is An Anti-Aging Pill Still Beyond Reach?
“If scientists are right, we may soon be taking a
pill that will give us a decade or two of healthy old age.” –
Morley Safer, CBS 60 MINUTES, January 25, 2009
In 1991 CBS 60 MINUTES first exposed the world to The
French Paradox, the fact the red wine-drinking French live longer
and are healthier, exhibiting a 30% reduction in mortality from heart
disease compared to western countries, despite their high-fat,
high-calorie diet. The 60 MINUTES report caused a temporary shortage
in red wine at the time.
But there will be no shortage of red wine this time –
researchers interviewed on 60 MINUTES said it would take 1000 bottles
of red wine to produce the same life-prolonging effects they achieved
in the animal laboratory. But were 60 MINUTES reporters misled?
Alert viewers are sending emails, inquiring online
about the inconsistencies in CBS’ 60 MINUTES report about resveratrol
(rez-vair-ah-trawl), the red wine molecule that is fast becoming a
household word, even if few can pronounce it.
The most glaring discrepancy was the bottle of
resveratrol pills shown on air. A picture of the bottle, provided by
the pharmaceutical company interviewed by 60 MINUTES, has been captured
and reproduced below. It’s not a drug at all.
Notice its label says “dietary supplement” and
“250 mg per capsule” on the label. This is not the SRT501
5000 mg plain resveratrol “drug” (microencapsulated, stabilized,
emulsified) that was first used in human clinical trials (see
side-by-side photos). It’s difficult to know whether the label shown
on 60 MINUTES was just made up for television viewing, or is an actual
product on the drawing board by the pharmaceutical company.
Why would a drug company, whose scientific experts
claim 1000 bottles of red wine, (providing ~1000 milligrams of
resveratrol) would be needed to produce a beneficial response in
humans, make a pill that provides 1/4th that amount?
Is mega-dose resveratrol needed to prolong human life
-- to achieve maximum lifespan -- as drug company researchers say?
They don’t need longevity pills in France. Their traditionally made,
dark, aged red wine confers super-longevity like that found in no other
country. Examine the following chart:
Country
Centenarian population
Total population
Centenarians per million population
Wine intake
/liters per annum
Caloric intake (2002)
France
20,000 (2008)
65 million
307.6
55.8
3653
Japan
36,000 (2008)
127 million
283.4
1.9
2760
United States
55,000 (2008)
305 million
180.3
8.7
3774
England
9,330 (2007)
58 million
160.8
18.9
3412
Roger Corder, author of THE WINE DIET and professor
of experimental therapeutics at the William Harvey Research
Institute in England, says resveratrol couldn’t possibly be responsible
for the health benefits derived from wine since a 5-ounce glass of wine
might provide just 1 mg of resveratrol. It is the total polyphenolic
(iron-binding) molecules, or about 60 mg per 5-ounce glass, that is
responsible for the unusual health of wine drinkers.
Almost magically, low-doses of an array of molecules
found in red wine (resveratrol, quercetin, catechin, kaempferol, gallic
acid, ferulic acid) appear to work better than mega-dose resveratrol
alone. A recent genomic study bears this out.
Researchers affiliated with the University of
Wisconsin conducted a global gene array study comparing calorie
restriction, plain resveratrol and a uniquely patented array of
molecules (resveratrol, quercetin, IP6 rice bran) found in
Longevinex®. At doses of resveratrol 17-320 times lower than prior
studies, Longevinex® activated 9-fold more longevity genes than plain
resveratrol or a calorie restricted diet. [Experimental Gerontology
2008 Sept; 43(9):859-66]
But again, something was amiss in the 60 MINUTES
report. University-based researchers interviewed on 60 MINUTES were
adept at showing how calorie restriction was working in primates
(monkeys), but these very same researchers conducted the above gene
array study and apparently never told CBS reporter Morley Safer that a
nutriceutical matrix (Longevinex®) far exceeds the genomic effect
produced by plainresveratrol or a limited calorie diet. The public was
deprived of hearing about a major breakthrough in longevity science.
The point of a well designed red wine pill is to
provide about the same quantity of mineral-controlling molecules
provided in 3-to-5 glasses of red wine, or about 180-300 mg, without
the alcohol, sugar, calories and sulfite preservatives, at a cost that
~5-6 times less than wine. A $6 bottle of wine would cost ~3-5 a day
to provide health benefits. The cost of Longevinex®, a red wine pill
designed to provide the equivalent amount of molecules found in 3-5
glasses of wine, is less than $1 per day.
Are the researchers intentionally misleading
consumers, holding them off from taking resveratrol as a dietary
supplement and telling them to wait for their stronger yet more
expensive resveratrol-like drug? In earlier pronouncements, drug
company spokespersons said resveratrol will take a back seat to more
potent “new chemical entities” and the company never plans to
introduce an anti-aging pill but rather to match resveratrol with an
anti-diabetic drug or a statin cholesterol-lowering drug to treat
disease.
The drug company claims it has stronger molecules
that will activate the Sirtuin1 longevity gene, by 1000-fold, but these
synthetic molecules are unproven, have never been used in humans, and
already the drug company has switched from one of these so-called “new
chemical entities” (SRT1720) to another (SRT2104) with no
explanation as to why.
Furthermore, while drug company researchers said “we
have a pill that can mimic the effects of a calorie restricted diet,”
and were bragging on television that their resveratrol pill prolonged
the life of laboratory mice, there was a big asterisk attached to that
statement. The researchers were referring to a 2006 study published in
Nature Magazine where mice were fed a 60% fat-calorie diet. But in
2008, a follow-up report published in the journal Cell Metabolism, this
time conducted among mice fed a standard fat-calorie diet (25%), showed
mega-dose resveratrol (360 and 1565 mg) shortened the lifespan of
mice. The higher dose produced a shorter lifespan. [Cell Metabolism
2008 Aug; 8(2):157-68] It’s best to stick with red wine, or low doses
in dietary supplements as found in red wine, preferably from an array
of molecules rather than just resveratrol.
Mr. Safer ended the 60 MINUTES report by saying: “Everybody
from plastic surgeons to snake oil salesmen have been promising a
ticket to eternal youth for some time. So the prospect of a
prescription pill that could trigger a longevity gene sounds too good
to be true. …. It’s a pill that diets for you, a pill that activates
the survival gene … a highly concentrated form of resveratrol, a
virtual vineyard of healthy living,” added Safer.
The script read well. It captured the attention of
millions. Yet the 60 MINUTES report was riddled with omissions,
apparent intentional distortions and exaggerations. If CBS’ Morley
Safer only knew.
Mr. Safer seemed ready for the pill. He ended the 60
MINUTES report this way: “The question is, when do WE get this
pill?”
- Copyright 2009 Resveratrol Partners LLC, not for
posting on other websites.
A depressing approach from Stanford:
http://news-service.stanford.edu/news/2009/january14/med-aging-011409.html
I don't know about you but I'm going to do everything
in my power to live as long as possible, because I do
not want to know what is on the other side, frankly...
My responsibility to my family, relatives, in-laws
and co-workers takes precedence over any personal
death-wish that a decaying society may wish to infuse
me with, which I refuse.
Something neat from Aubrey de Grey gives hope:
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=423155
And the remarkable interview of Sinclair and
Bush's misguided Medieval adviser Leon Kass:
http://realserver.bu.edu:8080/ramgen/w/b/wbur/storage/2004/01/theconnection_0106\
_2.rm
When Kass said we're not supposed to want to live
longer but instead live out our need for life through
our children, well, at that point I knew Bush was in
the 1500's or earlier as far as his science and thought
were concerned.
I will never vote for a mid-America candidate again, ever.
It is primitive thinking that goes on there. Inert, opaque,
vague, controlling, dogmatic, and inexact.
Stuart
Sensitive notes from a worldly-knowledgable man who
is in his late 50's...
I wouldn't want to live to be 100 in this world. In the
world I grew up in where three generations of each family
saw each other every week and ate at the same table,
I'd want to live in that age.
The problem is that it takes two generations to turn a
rotten society around. Two ... if you're lucky. Well,
we've got Gen-Y now in their twenties and they are
the end product of decadent, spoiled capitalism.
They CANNOT turn the ship around. Maybe their
children can.
I don't know if you observe very old people much. I
mean people older than 80. Most of them don't look
like they're having much fun. I would rather measure
my life by the LIFE IN MY YEARS RATHER THAN
THE YEARS IN MY LIFE. I'd rather have another
two good decades and then call it a day.
In an article published early online on January 21, 2009 in the
Proceedings of the National Academy of Sciences, researchers from
Brown University in Rhode Island, the University of Chicago, and the
University of Connecticut Health Center report that a mutation that
extends the lifespan of fruit flies works by limiting free radicals
and the damage they cause. Free radicals are highly reactive cellular
byproducts that damage tissue and contribute to many of the signs of
aging.
Professor Stephen Helfand of Brown's Department of Molecular Biology,
Cell Biology and Biochemistry and his associates sought to determine
the life-extending mechanism of a mutation named "Indy" (which stands
for "I'm not dead yet"), that he first discovered in 2000. Flies with
the Indy mutation have double the average life span as those without
it (70 versus 35 days). Dr Helfand's team compared gene expression in
Indy flies and normal flies throughout their lives and determined
that the mutation significantly limits the production of free
radicals known as reactive oxygen species via reduced expression of
genes involved in generating energy, without decreasing the overall
level of energy (as assessed by measuring adenosine triphosphate
levels) within the cell. Accordingly, protein carbonyls, a measure of
free radical damage to proteins, were lower in the mitochondrial
protein of Indy flies.
"There are very few, if any, interventions that are known to
dramatically extend healthy lifespan," Dr Helfand
stated. "Understanding how the Indy mutation alters the metabolic
state of the fruit fly would allow someone to come up with
pharmacological interventions that could mimic it and give you the
benefit of genetic manipulation without having to do genetics."
Overall, a pretty good segment on Resveratrol
on tonight's 60 Minutes seventeen years after
the French Paradox aired...
Morley Safer was his usual skeptical self
with sardonic wit (excellent characteristics
for a news anchor/reporter to have and
Morley is pretty seasoned.)
I was, of course, disappointed to see it so
centralized/dependent on the medical angle
however,
Why we have to have PhD's and MD's
force-feeding us to believe anything is
pretty sad... since the medical profession
is one of the most backward on earth
as far as accepting substantive improvement
rapidly. Many millions have died through the
centuries for its snail's pace of internalizing
change. Certainly, nowadays, with the implied
threat of litigation hanging over every physician's
head, true help is being often withheld for fear
of a lawsuit.
Also, no mention was made, as far as I could
tell, of overdosing on Resveratrol (>100mg/day)
which could lead to serious health consequences,
including death apparently.
No mention was made that some people have
reported that on 100mg/day of Resveratrol
an extreme hyper-reaction, extreme nervousness
and agitation -- many people do not want to live
that way or be seen like that... I have a close friend
and he has a close friend who had that reaction...
and ceased resveratrol immediately upon confirming
the above personal observations of each other, preferring
instead a laid-back persona/presentation. Both are
tenured professors and in the scientific field (computer science.)
Last, members of the CRS Caloric Restriction Society,
shown in the episode, looked very ill to me, dangerously
thin, emaciated, almost like prison-camp-detainees. I don't think
I'd want to go that route...
Stuart
http://www.sciencedaily.com/releases/2009/01/090116123129.htm
Scientists Discover Gene Responsible For Brain's Aging
ScienceDaily (Jan. 18, 2009) Will scientists one day be able to slow
the aging
of the brain and prevent diseases such as Alzheimer's and Parkinson's?
Perhaps --
at least once the genetic coding associated with neuronal degeneration
has been unraveled.
According to a new study published in The Journal of Neuroscience, a
research team
from the Universit de Montral, Maisonneuve-Rosemont Hospital and Lawrence
Berkeley National Laboratory has taken a giant step in this direction by
identifying
a gene that controls the normal and pathological aging of neurons in the
central
nervous system: Bmi1.
The primary risk factor for diseases such as macular degeneration,
Parkinson's and
Alzheimer's is age. Although many researchers have sought to better
understand the
genetics and pathophysiology of these diseases, few studies have focused
on the
basic molecular mechanisms that control neuronal aging.
Dr. Gilbert Bernier, of the Universit de Montral and Maisonneuve-Rosemont
Hospital, led a team that identified a mutation in mice that
dramatically accelerates
the process of aging in the brain and the eye. The new study reveals
that neurons
in the retina and cerebral cortex require a gene called Bmi1 to prevent
activation
of the p53 pathway and the accumulation of free radicals.
"Overall, we have now established that the Bmi1 gene is a direct
regulator of cell
aging in brain and retinal neurons of mammals through its action on the
defense
mechanisms against free radicals," says Dr. Bernier.
The article is the work of Dr. Gilbert Bernier in collaboration with
Wassim Chatoo,
Mohammed Abdouh, Jocelyn David, Marie-Pier Champagne, Jos Ferreira from
the Universit de Montral and Maisonneuve-Rosemont Hospital with Francis
Rodier from the Lawrence Berkeley National Laboratory, San Francisco, U.S.
In light of the recent question over whether red wine resveratrol pills
actually deliver on their promise to prolong human life, the following
was sent to a critical reviewer.
*IN DEFENSE OF A RED WINE RESVERATROL PILL*
*Sandy Szwarc/ Junk Food Science*
Your report at Junk Food Science regarding resveratrol piils is an
honest attempt to provide consumers with a critical review.
http://junkfoodscience.blogspot.com/2008/12/living-longer-with-resveratrol.html
However, may I add some things for you to think about.
First, Thomas Walle's work should be discredited. It is misleading and
sponsored by a drug company.
It is obvious from other studies that systemic effects are produced by
resveratrol. Its effects are not limited to the gut. Yes, free
(unbound) resveratrol is not commonly found in the blood circulation.
Once it reaches the liver it is conjugated with glucuronate or sulfate,
which are detox molecules. The res/glucuronate conjugate is too large
to pass through cell walls and influence genetic machinery. However,
glucuronidase is an enzyme that is abundant at sites of inflammation,
infection and malignancy and it free resveratrol to be delivered at the
right time and place.
http://www.ncbi.nlm.nih.gov/pubmed/19114588?http://www.ncbi.nlm.nih.gov/pubmed/15349955?
Second, we cannot call for longevity studies in humans, this is
impractical. 99-year studies would be required. So researchers are
forced to use animals. Even 3-4 year mouse studies are costly. Yes,
some human trials are on the way, but would only prove what has already
been observed in animals, they are profoundly healthier, but may die
sooner. This is a bit of a paradox (explained below). Gene array
testing may serve as a valid shortcut to longevity studies (see more
below).
http://www.ncbi.nlm.nih.gov/pubmed/11238786?http://www.ncbi.nlm.nih.gov/pubmed/10906510?http://www.ncbi.nlm.nih.gov/pubmed/10464095?
Third, the positive health benefits of red wine molecules like
resveratrol are observed and repeatedly demonstrated in animal studies
and by epidemiology ONLY in relatively lower doses and when an array of
molecules are employed. Aged, dark red wine provides ~60 mg of
polyphenolic molecules (resveratrol, quercetin, catechin, gallic acid,
kaempferol, ferulic acid, etc) per 5 oz glass of wine. A U-shaped
consumption curve is revealed. Abstainers and over-imbibers exhibit no
benefits. Consumers of 3-5 glasses of red wine, providing ~180-300 mg
of total polyphenols, exhibit profound and repeated health benefits,
i.e. 30% reduced cardiac mortality among French red wine drinkers.
http://www.ncbi.nlm.nih.gov/pubmed/8814971?http://www.ncbi.nlm.nih.gov/pubmed/12965884?
Resveratrol appears to exert profound beneficial effects are very low
concentrations.
http://www.ncbi.nlm.nih.gov/pubmed/18234130?
The beneficial effects of red wine molecules are additive:
http://www.ncbi.nlm.nih.gov/pubmed/15740983?
Fourth, there are synergistic effects observed when polyphenolic
molecules are combined.
http://www.ncbi.nlm.nih.gov/pubmed/19053873?http://www.ncbi.nlm.nih.gov/pubmed/18495457?http://www.ncbi.nlm.nih.gov/pubmed/18433793?http://www.ncbi.nlm.nih.gov/pubmed/16935024?http://www.ncbi.nlm.nih.gov/pubmed/16310197?http://www.ncbi.nlm.nih.gov/pubmed/15670891?http://www.ncbi.nlm.nih.gov/pubmed/12888656?http://www.ncbi.nlm.nih.gov/pubmed/11743756?
Fifth, lower doses of resveratrol appear to genomically mimic calorie
restriction:
http://www.ncbi.nlm.nih.gov/pubmed/18523577
Sixth, it has been shown that relatively lower doses of resveratrol when
combined in a matrix of mineral-chelating molecules exerts a far greater
genomic effect than plain resveratrol. (I am commercially involved with
this product, Longevinex). At a dose of resveratrol 17-320 times lower
than prior studies, a resveratrol/quercetin/rice bran IP6
matrix significantly affected 1711 genes, but only 225 genes as plain
resveratrol alone.
http://www.ncbi.nlm.nih.gov/pubmed/18657603?
Seventh, the molecules in red wine are known TNF inhibitors. There are
many other natural molecules that are TNF inhibitors (vitamin E, fish
oil, vitamin C, curcumin, etc.). Over-inhibition of TNF is associated
with increased risk for lymphoma.
http://www.ncbi.nlm.nih.gov/pubmed/18360633?http://www.ncbi.nlm.nih.gov/pubmed/17654504?
The animals in the 2008 Cell Metabolism study did not live as long on
360 mg or 1565 mg human equivalent of resveratrol compared to a standard
calorie diet alone. The animals tended to die of lymphoma.
http://www.ncbi.nlm.nih.gov/pubmed/18599363?
I believe it was the over-inhibition of TNF that shortened the lives of
these lab animals. Dosage would then be critical in achieving health
benefits, as over-inhibition of TNF may be deleterious.
Eighth, relatively lower doses of resveratrol (175-350 mg human
equivalent) appear to protect the heart from damage should a heart
attack occur, while larger doses (often provided in some mega-dose
resveratrol supplements) may worsen the area damaged (scarred) by a
heart attack (1750-3500 mg human equivalent). Mega-dose resveratrol is
more appropriate to induce apoptosis, such as for cancer therapy.
http://www.ncbi.nlm.nih.gov/pubmed/18789672?
Ninth, provision of mega-doses of the molecules in red wine, as well as
in bran, as mineral chelators, may induce anemia and resultant side
effects. For example, resveratrol is a copper chelator and copper is
needed for collagen synthesis. Achilles tendonitis is commonly reported
among users of mega-dose resveratrol and may be due to weak collagen.
Resveratrol and other mineral chelating molecules are not appropriate
for menstruating females, growing children, or known anemics.
The beneficial effects of red wine may be safely replicated in a pill
that provides a modest dose (180-300 mg) of red wine polyphenols or
other mineral-chelating molecules, as provided in 3-5 glasses of aged,
dark, red wine, and such a pill eliminates the hazards posed by alcohol,
excess calories, sugar, heavy metals and sulfite preservatives found in
wine. Such a pill would also be far more affordable than 3-5 glasses of
red wine.
Bill Sardi, Resveratrol Partners LLC, dba LONGEVINEX
------------------------------------------------------------------------
New year...new news. Be the first to know what is making headlines
<http://www.aol.com/?ncid=emlcntaolcom00000026>.
--Stuart
___
Sent via Treo 700p using SnapperMail 2.4.1.01 on the EVDO REV-A Verizon
Wireless Network.
..... Forwarded Message .......
From: Stuart Cracraft <cracraft@...>
To: forumpoint@yahoogroups.com
Date: Sat, 27 Dec 2008 15:15:24 -0800
Subj: [forumpoint] Fwd: Modest doses of resveratrol suggested for longevity
seekers
--Stuart
___
Sent via Treo 700p using SnapperMail 2.4.1.01 on the EVDO REV-A Verizon
Wireless Network.
..... Forwarded Message .......
From: BSardi@...
To: gerrygawne@...
Date: Sat, 27 Dec 2008 12:09:45 EST
Subj: Modest doses of resveratrol suggested for longevity seekers
For Immediate Release
Longevity Seekers Advised To Consume Modest Doses of Red Wine Molecules In
Dietary Supplements (Longevinex®) Rather Than Mega-Dose Resveratrol Alone
San Dimas, CA (Dec. 27, 2008) - According to the latest science, resveratrol
pill users are best advised to consume modest doses resveratrol plus an array of
antioxidant molecules as typically provided in 3 to 5 glasses of aged, red wine,
rather than resveratrol alone.
The most recent study shows mega-dose resveratrol alone fails to prolong the
life of laboratory mice. In fact, mega-doses shortened the life of animals
compared to a standard calorie diet with no resveratrol. [Cell Metabolism. 2008
Aug; 8:157-68]
While resveratrol (rez-vair-ah-trol), an antioxidant molecule concentrated in
red wine (about 1 milligram per glass), is touted for its health properties,
partially explaining the French Paradox (why French wine drinkers have cardiac
mortality rates 30% lower than North Americans despite their high-calorie,
high-fat diets), it is not the sole molecule responsible for longevity, says
Bill Sardi, spokesperson for Longevinex®, a leading brand of resveratrol
dietary supplement.
The total array of red wine molecules found in the best red wine, about 60
milligrams per 5-ounce glass, or 180-300 milligrams in 3 to 5 glasses, is the
suggested healthy dosage range, says Sardi.
Consistently, studies show modest doses of red wine lower mortality rates over
abstention or over-consumption. [American Journal Epidemiology 1986 Sep;
124(3):481-9] Red wine pills offer the advantage of no alcohol, no calories or
sulfite preservatives.
Cause of shortened lifespan
The negative effect upon lifespan with mega-dose resveratrol may emanate from
over-inhibition of tumor necrosis factor (TNF), an inflammatory factor.
Excessive TNF leads to inflammation, while too little impairs the immune system,
says Sardi.
“We know that over-inhibition of TNF in humans increases the risk for lymphoma
(cancer that originates in lymphocytes, a type of white blood cell),” says
Sardi. [Therapeutics Clinical Risk Management 2007 Jun; 3(2):245-58] “When
laboratory mice were given mega-dose resveratrol they did not live as long and
largely succumbed to lymphoma. Resveratrol is a known TNF inhibitor,” adds
Sardi. [Biochemical and Biophysical Research Communications 2008 May 2;
369(2):471-7]
Confusing dosage advice
While longevity seekers have been hearing a lot about resveratrol in the past
four years, since an Ivy League university discovered it activated a longevity
gene known as Sirtuin 1, advice concerning dosage has been confusing at times.
A 2006 mouse study suggested consumers would have to drink about 750 to 1500
bottles of red wine a day to live longer (24 milligrams per kilogram of body
weight), but the longevity effect was only demonstrated among mice engorged with
a fat-laden diet (60% fat calories vs. 35% for the typical human diet), which
isn’t a real-world example.
When the data on mice fed a standard calorie diet were analyzed and published in
2008 [Cell Metabolism. 2008 Aug; 8(2):157-68], ultra-high dose resveratrol (360
mg and 1565 mg, human equivalent dosage) actually stunted the lifespan of mice.
So the public has been misled concerning dosage since 2006 [Nature 2006 Nov 16;
444:337-42], and may have never heard about the 2008 report, says Sardi.
Lower dose resveratrol accompanied by an array of other small molecules may be
superior to resveratrol alone. According to a mouse study conducted by
Longevinex®, published in the September 2008 issue of Experimental Gerontology
[2008 Sept; 43(9):859-66], far more longevity genes were activated in heart
tissue by Longevinex (9-fold more) than plain resveratrol, at a dose that was
17-320 times lower than doses used in prior studies.
Synergism found
“A synergistic effect has been demonstrated with the array of antioxidant
molecules provided in Longevinex®, compared to resveratrol alone,” says
Sardi. Other studies also corroborate that resveratrol works better when
accompanied by other molecules, at lower doses. [Journal Medicinal Food 2008
Dec; 11:773-83; Translational Oncology 2008 March; 1:19-27; Life Science 2008
May 7; 82: 1032-9]
Sardi says longevity seekers often demand human lifespan studies, not realizing
such a study would be impractical, taking 100 years to complete. Mouse
longevity studies take about 3-4 years and cost more than a million dollars, so
more economical gene array studies are performed and compared against a calorie
restricted diet, which is a known intervention that prolongs life in all life
forms. Longevinex® also sponsored an unpublished study showing it activated
far more genes in brain tissue than plain resveratrol.
Longevinex® is a patent-applied-for matrix providing 250 milligrams of
gene-controlling molecules (resveratrol, quercetin, rice bran IP6, ferulic acid,
vitamin D), and is currently the only resveratrol-based dietary supplement to
have been successfully studied in humans. Researchers at Appalachian State
University found Longevinex® had superior antioxidant and anti-inflammatory
action among endurance athletes compared to green tea molecules or quercetin
alone.
Longevinex® is microencapsulated for stability and long-term shelf life, and is
micronized to enhance absorption. Longevinex® contains no alcohol. Longevity
seekers are invited to visit the website at www.longevinex.com ####
---------------
One site keeps you connected to all your email: AOL Mail, Gmail, and Yahoo Mail.
Try it now.
------------------------------------
Yahoo! Groups Links
http://www.msnbc.msn.com/id/28369049/
Just get off your feet, lay down, close your eyes
and stay in bed, horizontal, for 8 hours, nightly,
the rest of your life.
Add resveratrol and you have a good situation!
In a study that adds evidence to what chocolate lovers, tea drinkers,
and wine aficionados have been claiming for years, A. David Smith of
the University of Oxford in England and his colleagues have
demonstrated that these foods do appear to be good for the brain.
Writing in the December, 2008 issue of the Journal of Nutrition, Dr
Smith and his associates describe their study of 2,031 men and women
aged 70 to 74 recruited from the Hordaland Health Study in Norway.
Responses to dietary questionnaires were analyzed for the intake of
wine, tea, and chocolate--common dietary items that are high in
flavonoids. Cognitive evaluation included six tests of memory and
learning.
Subjects who reported consuming wine, chocolate or tea had
significantly better average cognitive test scores and than
nonconsumers. The risk of performing poorly on the cognitive tests
decreased as a greater number of the three foods were consumed, with
a 64 to 74 percent reduction in the risk of poor test performance
associated with the intake of all three compared to the risk
experienced by those who did not consume these foods.
In their discussion of the possible effects of these foods upon the
brain, the authors note that wine drinkers have been shown to have a
lower risk of dementia compared with nondrinkers, cocoa is a rich
source of flavonoids which have antioxidant benefits, and green tea
polyphenol intake has been correlated with a reduction in cognitive
impairment.
"In a population-based study, we showed that intake of flavonoid-rich
food, including chocolate, wine, and tea, is associated with better
performance across several cognitive abilities and that the
associations are dose dependent," the authors conclude. "We suggest
that further studies should directly examine the flavonoid status and
take into account other bioactive dietary substances in these foods."
It bears repeating: "red wine (1 glass daily) and/or
resveratrol supplementation in amounts of 50mg to 100mg daily)
leads to inhibition and prevention of breast cancer
(as well as many other cancers):
http://www.newswise.com/articles/view/542194/http://www.ivanhoe.com/channels/p_channelstory.cfm?storyid=19919
It is a stronger inhibitor than exercise or diet (and far, far easier than
control of either of those.)
The literature is literally now OVERFLOWING with enormous numbers
of studies that point in the same direction as the above. You can
review them for yourself if you wish at www.pubmed.org by
searching on the keyword "resveratrol".
There are 2555 pro-resveratrol articles there. That's hard research
backing up one of nature's very few miracle molecules, one of the
very few that is far more powerful than most man-created molecules.
I get mine at www.longevinex.com, which also happens to be the BEST
formulation.
Stuart
P.S. This is the last e-mail you will receive on this specific subject
from me for a long time. I've had my say. It's up to you to care for
yourselves!!!!
And don't forget: it slows neuron decay/loss in the brain, ameliorates
plaque (those two contribute to Alzheimer's, Senility, Parkinson's
and other brain-wasting/damage diseases), and is one of the most
strongly pro-cardia (heart) approaches in the world. It's a wonder
you can even buy it without some doctor overcharging you for an
opinion! I'm surprised the government hasn't banned it, frankly.
Have a great Winter Solstice all.
Researchers
at the Weill Medical College of Cornell University report that dietary
supplementation with the red wine molecule resveratrol
(rez-vair-ah-trawl) dramatically reduces plaque formation in
animal
brains, surprisingly without activating the Sirtuin1 gene.
Oral
resveratrol produced large reductions in brain plaque in the
hypothalamus (-90%), striatum (-89%), and medial cortex (-48%) sections
of the brain. Previously, studies had shown that direct injection of
resveratrol into brain tissues reduces degeneration and prevents
learning impairment. This study shows that oral doses of resveratrol
may reduce beta amyloid plaque associated with aging changes in the
brain. Researchers theorize that one mechanism for plaque eradication
is the ability of resveratrol to chelate (remove) copper.
[Neurochemistry International, Nov. 8, 2008 early online]
Plaque
counts
Percent
plaque area
Abstract:Neurochemistry International 2008 Nov 8. [Epub
ahead of print]
Dietary
supplementation with
resveratrol reduces plaque pathology in a transgenic model of
Alzheimer's disease.
Department
of Neurology and Neurosciences, Weill Medical College of Cornell
University, Burke Medical Research Institute, 785 Mamaroneck Ave.,
White Plains, NY 10605, United States.
Resveratrol,
a polyphenol found in red wine, peanuts, soy beans, and pomegranates,
possesses a wide range of biological effects. Since resveratrol's
properties seem ideal for treating neurodegenerative diseases, its
ability to diminish amyloid plaques was tested. Mice were fed
clinically feasible dosages of resveratrol for forty-five days. Neither
resveratrol nor its conjugated metabolites were detectable in brain.
Nevertheless, resveratrol diminished plaque formation in a region
specific manner. The largest reductions in the percent area occupied by
plaques were observed in medial cortex (-48%), striatum (-89%) and
hypothalamus (-90%). The changes occurred without detectable activation
of SIRT-1 or alterations in APP processing. However, brain glutathione
declined 21% and brain cysteine increased 54%. The increased cysteine
and decreased glutathione may be linked to the diminished plaque
formation. This study supports the concept that onset of
neurodegenerative disease may be delayed or mitigated with use of
dietary chemo-preventive agents that protect against beta-amyloid
induced neuronal damage.
Researchers
at the Weill Medical College of Cornell University report that dietary
supplementation with the red wine molecule resveratrol
(rez-vair-ah-trawl) dramatically reduces plaque formation in animal
brains, surprisingly without activating the Sirtuin1 gene.
Oral
resveratrol produced large reductions in brain plaque in the
hypothalamus (-90%), striatum (-89%), and medial cortex (-48%) sections
of the brain. Previously, studies had shown that direct injection of
resveratrol into brain tissues reduces degeneration and prevents
learning impairment. This study shows that oral doses of resveratrol
may reduce beta amyloid plaque associated with aging changes in the
brain. Researchers theorize that one mechanism for plaque eradication
is the ability of resveratrol to chelate (remove) copper.
[Neurochemistry International, Nov. 8, 2008 early online]
Plaque
counts
Percent
plaque area
Abstract:Neurochemistry International 2008 Nov 8. [Epub
ahead of print]
Dietary supplementation with
resveratrol reduces plaque pathology in a transgenic model of
Alzheimer's disease.
Department
of Neurology and Neurosciences, Weill Medical College of Cornell
University, Burke Medical Research Institute, 785 Mamaroneck Ave.,
White Plains, NY 10605, United States.
Resveratrol,
a polyphenol found in red wine, peanuts, soy beans, and pomegranates,
possesses a wide range of biological effects. Since resveratrol's
properties seem ideal for treating neurodegenerative diseases, its
ability to diminish amyloid plaques was tested. Mice were fed
clinically feasible dosages of resveratrol for forty-five days. Neither
resveratrol nor its conjugated metabolites were detectable in brain.
Nevertheless, resveratrol diminished plaque formation in a region
specific manner. The largest reductions in the percent area occupied by
plaques were observed in medial cortex (-48%), striatum (-89%) and
hypothalamus (-90%). The changes occurred without detectable activation
of SIRT-1 or alterations in APP processing. However, brain glutathione
declined 21% and brain cysteine increased 54%. The increased cysteine
and decreased glutathione may be linked to the diminished plaque
formation. This study supports the concept that onset of
neurodegenerative disease may be delayed or mitigated with use of
dietary chemo-preventive agents that protect against beta-amyloid
induced neuronal damage.
Bulletin
From Longevinex®: Resveratrol Sends Survival or Death Signals,
Depending Upon Dosage
San Dimas, CA (Dec. 18, 2008) - Relatively low
oral doses of the red wine molecule resveratrol (rez-vair-ah-trawl)
send survival signals and protect heart tissues from damage should a
heart attack occur, but supra-high doses completely reverse this
survival effect and send a cellular death signal that worsens heart
damage when a heart attack is intentionally induced in laboratory
animals. On the other hand, supra-high dose resveratrol sends a
cellular death signal that may be advantageous in the treatment of
cancer.
These are the recent findings of Dipak K. Das
PhD, and colleagues, at the Cardiovascular Research Center, University
of Connecticut School of Medicine, Farmington, Connecticut, as reported
in an upcoming issue of the Journal of Nutritional Biochemistry.
Supra-high dose resveratrol supplements
(Biotivia, Rev Genetics, Redmedin) were first marketed in 2006 when a
mouse study suggested high-dose resveratrol (~1565 milligrams) reverses
some of the effects of a high-fat diet. However, this study employed a
60% fat-calorie diet which cannot be applied to humans who consume ~30%
fat-calorie diet. [Nature. 2006 Nov 16; 444(7117):337-42] Later it
was shown the lifespan of laboratory mice on this dose (1565 mg) was
shortened when placed on a standard calorie diet. [Cell Metabolism
2008 Aug; 8(2):157-68]
In the recent University of Connecticut animal
study, researchers found the human equivalent of 175 and 350 mg of
resveratrol sends cell survival signals, while 1750 and 3500 milligrams
for a 160-lb human sends death signals to cells. Supra-high dose
resveratrol demonstrably increased the area of dead tissue in the heart
after a 30-minute period where the heart was deprived of oxygen, but
actually reduced the size of a heart attack in lower doses.
The mechanism behind this dual nature of
resveratrol may now be understood. Researchers believe supra-high dose
resveratrol may cause iron to accumulate that promotes oxidation and
destruction of cells. This would be advantageous in the treatment of
cancer, to selectively induce cell death, whereas among healthy adults,
this appears to be potentially harmful.
“Some resveratrol pill makers advocated doses
up to 7000 mg per day without adequate scientific substantiation,”
says Bill Sardi, a spokesperson for Longevinex®, a leading brand
resveratrol pill. “Resveratrol pills in 500 mg and 1000 mg doses
were offered and thousands of consumers bought the pills. Some makers
of the mega-dose resveratrol pills went so far as to ridicule
lower-dose pills, citing the 2006 mouse study in Nature magazine where
the animals were placed on such a high fat diet that the experiment in
no way was applicable to humans,” he says.
“Consumers were also errantly advised to
wait for stronger pills that a pharmaceutical company was developing, a
resveratrol-like pill that would activate a particular gene 1000-fold
better than plain resveratrol. But subsequent animal studies showed
more than 7.5 fold activation of that gene (Sirtuin1) induces heart
failure in animals. [Circulation Research 2007;
100:1512]. We now know mega-dose resveratrol may not be
beneficial, and appears to be deleterious for healthy adults,” adds
Sardi.
More recently, Longevinex® ( www.longevinex.com
) sponsored a mouse study which showed its proprietary and
patent-applied for blend of nutriceuticals, which includes 100 mg of
resveratrol per capsule, and 250 mg of natural mineral-chelating
molecules overall (about the same amount of molecules provided in 3-5
glasses of red wine), favorably influenced 1711 longevity genes in
heart tissue, compared to only 225 genes in animals fed 100 mg of plain
resveratrol. [Experimental Gerontology 2008 Sep; 43(9):859-66] -
Copyright 2008 Resveratrol Partners LLC, dba Longevinex. Not for
posting on other websites.
Extent of damage to animal heart
tissue by dosage of resveratrol.
White area in photos below represents scarred tissue.
The equivalent of 2.5 mg per kilogram of body weight of resveratrol
in a 160-lb human = 175 mg; 5.0 mg/kilogram = 350 mg;
25 mg/kilogram = 1750 mg; 50 mg/kilogram = 3500 mg.
Heart cell (cardiomyocyte) death
during an induced
heart attack, by dosage of resveratrol. Lower doses
reduced cell death and exhibit protection for heart tissues,
mega-doses increased cell death and increased the area
of scarred tissue in the heart.